Jennifer Brown, MD, PhD discusses results form the ALPINE trial
Dana-Farber
December 22, 2025
Symptom-based progression-free survival (S-PFS) as a clinically relevant and patient-centric endpoint in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)